You watched
Catalog
Client
Currency:
+380 66 708 47 52
Our location:
Ternopil city
Phones:
E-mail
We are on social networks
Go to contacts
0 0
Catalog
Main page
Viewed
20
Wishlist
0
Compare
0
Contacts

Longocaine solution for injection 5 mg/ml ampoule 5 ml No. 10

SKU: an-51052
0
All about product
Description
Specification
Reviews 0
Questions0
new
Longocaine solution for injection 5 mg/ml ampoule 5 ml No. 10
Longocaine solution for injection 5 mg/ml ampoule 5 ml No. 10
Longocaine solution for injection 5 mg/ml ampoule 5 ml No. 10
Longocaine solution for injection 5 mg/ml ampoule 5 ml No. 10
In Stock
639.82 грн.
Buy this product in 1 click:
Active ingredient:Bupivacaine
Adults:Can
ATC code:N NERVOUS SYSTEM AGENTS; N01 ANESTHETICS; N01B LOCAL ANESTHETICS; N01B B Amides; N01B B01 Bupivacaine
Country of manufacture:Ukraine
Diabetics:Can
Delivery
USPS across the USA USPS across the USA
Canada Post across Canada Canada Post across Canada
Payment
Longocaine solution for injection 5 mg/ml ampoule 5 ml No. 10
639.82 грн.
Description

Longocaine, 0.5% solution, is used for local anesthesia by percutaneous infiltration, peripheral nerve block(s) and central nerve block (caudal or epidural), i.e., by a specialist in situations where prolonged anesthesia is required. Since sensory nerve block is more pronounced than motor block, Longocaine is particularly effective in relieving pain, for example, during childbirth.

Composition

Active ingredient: bupivacaine;

1 ml of solution contains bupivacaine hydrochloride anhydrous;

Excipients: sodium chloride, water for injections.

Contraindication

Hypersensitivity to amide-type local anesthetics or to any of the other ingredients of the drug. Bupivacaine should not be used for intravenous regional anesthesia (Bieri block). Bupivacaine should not be used for epidural anesthesia in patients with severe hypotension, for example, in the case of cardiogenic or hypovolemic shock. Epidural anesthesia, regardless of the local anesthetic used, has its own contraindications, which include: diseases of the nervous system in the active stage, such as meningitis, poliomyelitis, intracranial hemorrhage, subacute combined degeneration of the spinal cord due to pernicious anemia and tumors of the brain and spinal cord; tuberculosis of the spine; purulent skin infection at or near the site of the lumbar puncture; blood clotting disorders or current treatment with anticoagulants.

Method of application

The drug should be administered by a physician experienced in regional anesthesia or under his supervision. Small doses should be used to achieve a sufficient degree of anesthesia.

Application features

Pregnant women

Should not be used in early pregnancy unless the benefits are considered to outweigh the risks.

Children

Use for anesthesia in children aged 1 year and older as directed.

Drivers

With caution.

Overdose

Accidental intravascular injections of local anesthetics can cause immediate (seconds to minutes) systemic toxic reactions. In case of overdose, systemic toxicity occurs later (15-60 minutes after injection) due to the slower increase in blood concentrations of the local anesthetic.

Side effects

Adverse reactions caused by the drug itself are difficult to distinguish from the physiological effects of nerve fiber blockade (e.g., decreased blood pressure, bradycardia), as well as phenomena caused directly (e.g., nerve injury) or indirectly (e.g., epidural abscess) by needle puncture.

Interaction

Caution should be exercised when using bupivacaine with drugs structurally similar to local anesthetics, such as class IC antiarrhythmics, as their toxic effects are additive.

Specific interaction studies between local anesthetics and class III antiarrhythmics (e.g. amiodarone) have not been performed, but caution is advised in this case.

Storage conditions

Store at a temperature not exceeding 25 °C.

Do not freeze. Keep out of reach of children.

Shelf life - 2 years.

Specifications
Characteristics
Active ingredient
Bupivacaine
Adults
Can
ATC code
N NERVOUS SYSTEM AGENTS; N01 ANESTHETICS; N01B LOCAL ANESTHETICS; N01B B Amides; N01B B01 Bupivacaine
Country of manufacture
Ukraine
Diabetics
Can
Dosage
5 mg/ml
Drivers
With caution
For allergies
With caution
For children
It is impossible.
Form
Ampoules
Method of application
Injections
Nursing
Can
Pregnant
With caution in early pregnancy
Primary packaging
ampoule
Producer
Yuria-Pharm LLC
Quantity per package
10 ampoules
Trade name
Longocaine
Vacation conditions
By prescription
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.

You are watched
new
new
Sold out
Aclasta solution for infusion 5 mg/100 ml bottle 100 ml No. 1
Распродано
0
12 423.40 грн.
new
Rapten 75 solution for injection ampoule 3 ml No. 5
In stock
0
260.78 грн.
new
Neurodar solution for injection 500 mg/4 ml ampoule No. 5
In stock
0
909.50 грн.
new
Sold out
new
Sold out
Silicone pacifier Avent scf042/27 super soft slow flow No. 2
Распродано
0
446.10 грн.
new
TAVARGYN R-R 100ML
In stock
0
565.06 грн.
new
new
Pallada eye drops solution 1 mg/ml dropper bottle 5 ml
In stock
0
474.35 грн.
new
Benoxy eye drops 0.4% dropper container 10 ml
In stock
0
334.35 грн.
639.82 грн.